<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20251024067740N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-11-04</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Comparing the Effectiveness of Cognitive-Behavioral Therapy and Mindfulness-Based Stress Reduction in people with Mild Cognitive Impairments</public_title>
      <acronym></acronym>
      <scientific_title>Comparing the Effectiveness of Cognitive-Behavioral Therapy and Mindfulness-Based Stress Reduction on Quality of Life, Perceived Stress, Attention and Working Memory in Individuals with Mild Cognitive Impairments.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-11-08</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>45</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/87115</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients diagnosed with Mild Cognitive Impairment (MCI) will be randomly assigned to the intervention and control groups using a lot-drawing randomization method. Each participant was assigned a unique number, and the sample numbers were then randomly selected using the Excel software to determine group allocation, Blinding description: participants are unaware of the intervention identity. Allocation uses neutral codes (A/B).</study_design>
      <phase>N/A</phase>
      <hc_freetext>Mild Cognitive Impairment.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:Cognitive-Behavioral Therapy, Cognitive Behavioral Therapy (CBT), based on the classical cognitive-behavioral approach, will be conducted with the aim of improving the cognitive, behavioral, and emotional states of participants in the experimental group through nine group therapy sessions, held once a week, each lasting 90 minutes. Intervention 2: Intervention group:Mindfulness-Based Stress Reduction, The Mindfulness-Based Stress Reduction (MBSR) program will be conducted in eight weekly sessions. Each session will typically last for two and a half hours and will follow a structured program. Intervention 3: Control group:No intervention، They were included in the study for comparison with the intervention groups and did not receive any medication, placebo, or treatment.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No further information is available.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Anahita Tarki</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 12, Pirooz Street., Shariati Ave., Tehran Town,. Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1661743539</zip>
        <telephone>+98 21 2670 0944</telephone>
        <email>anahitatarki2013@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Anahita Tarki</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 12, Pirooz Street., Shariati Ave., Tehran Town</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1661743539</zip>
        <telephone>+98 21 2670 0944</telephone>
        <email>anahita.tarki@iau.ac.ir</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Receiving a confirmed diagnosis of Mild Cognitive Impairment (MCI) by a neurology specialist.
Being between 60 and 80 years of age.
Fluency in Persian language and having at least 8 years of formal education.
The participant’s ability to attend treatment sessions as scheduled according to the therapeutic protocols and to regularly perform the exercises related to each intervention.
The ability to write and fully complete the questions of self-report instruments and computer-based tools across the three stages of implementation.</inclusion_criteria>
      <agemin>60 years</agemin>
      <agemax>80 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>A confirmed diagnosis of any type of progressive dementia.
Having progressive neurological disorders, or a diagnosed cognitive impairment resulting from conditions such as COVID-19 infection, brain injury, stroke, multiple sclerosis (MS), Parkinson’s disease, or other similar causes.
Absence from more than four sessions in any of the intervention programs.
Exacerbation of symptoms, hospitalization, or undergoing anesthesia and surgery during the implementation of the protocols.
Presence of severe visual or hearing impairments, history of stroke, transient ischemic attack (TIA), or head injury with a history of loss of consciousness.
History of internal medical conditions such as uncontrolled diabetes, uncontrolled hypertension, uncontrolled hyperlipidemia, obstructive sleep apnea, or a history of HIV infection.
Presence of major neurological or psychiatric disorders, including stroke, epilepsy, seizures, Parkinson’s disease, multiple sclerosis (MS), brain injuries, diagnosed schizophrenia, adult attention-deficit/hyperactivity disorder (ADHD), or any condition requiring frequent hospital visits or hospitalizations.
Dependence on or abuse of substances or specific medications.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G31.84</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Mild cognitive impairment, so stated</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:Cognitive-Behavioral Therapy, Cognitive Behavioral Therapy (CBT), based on the classical cognitive-behavioral approach, will be conducted with the aim of improving the cognitive, behavioral, and emotional states of participants in the experimental group through nine group therapy sessions, held once a week, each lasting 90 minutes.</i_keyword>
      <i_keyword>Intervention group:Mindfulness-Based Stress Reduction, The Mindfulness-Based Stress Reduction (MBSR) program will be conducted in eight weekly sessions. Each session will typically last for two and a half hours and will follow a structured program.</i_keyword>
      <i_keyword>Control group:No intervention، They were included in the study for comparison with the intervention groups and did not receive any medication, placebo, or treatment.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Quality of Life. Timepoint: Before the intervention – Immediately after the intervention – Three-month follow-up after the intervention. Method of measurement: world health organization- quality of life questionnaire (WHOQOL-100).</prim_outcome>
      <prim_outcome>Perceived Stress. Timepoint: Before the intervention – Immediately after the intervention – Three-month follow-up after the intervention. Method of measurement: percieved stress scale-14 (PSS-14).</prim_outcome>
      <prim_outcome>Attention. Timepoint: Before the intervention – Immediately after the intervention – Three-month follow-up after the intervention. Method of measurement: Cambridge Neuropsychological Test Automated Battery (CANTAB) will be used in the subtests of Rapid Visual Information Processing (RVP) and Match to Sample Visual Search (MTS).</prim_outcome>
      <prim_outcome>Working Memory. Timepoint: Before the intervention – Immediately after the intervention – Three-month follow-up after the intervention. Method of measurement: Cambridge Neuropsychological Test Automated Battery (CANTAB) in the Spatial Working Memory (SWM) subtest.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University, Karaj Branch</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-04-23</approval_date>
        <contact_name>Research Ethics Committees of Islamic azad University - Karaj Branch</contact_name>
        <contact_address>Islamic Azad University, Karaj Branch, Shahid Chamran Boulevard, Karaj, Alborz Province, Iran karaj Alborz Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
